# Metformin at the Cellular Level and Dosing for Diabetes Mellitus (DM)

> **NCT01876992** · NA · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 10 (actual)

## Conditions studied

- Diabetes
- Pre-diabetes
- Obesity

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01876992
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** All investigators/co-investigators relocating to other institutions.
- **Last updated:** 2017-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01876992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01876992, "Metformin at the Cellular Level and Dosing for Diabetes Mellitus (DM)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01876992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*